Armata Pharmaceuticals Inc (ARMP) Stock Analysis

Armata Pharmaceuticals Inc (ARMP) is a publicly traded company in the HEALTHCARE sector. It trades at $7.90, carries a market capitalization of $286.34M. This page summarizes the public market data, fundamentals, and frequently asked questions for ARMP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

Market Sentiment

Armata Pharmaceuticals Inc currently has a Neutral sentiment score of -0.13.

About Armata Pharmaceuticals Inc

Armata Pharmaceuticals Inc. is a clinical-stage biotechnology company based in Marina del Rey, California, focused on developing innovative bacteriophage-based therapies to tackle the escalating threat of antibiotic-resistant infections. By harnessing advanced technologies and deep research expertise, Armata aims to deliver precision medicine solutions that address urgent needs in infectious disease management. The company is building a robust pipeline of therapeutic candidates and establishi...

GNG Research Analysis

GNG Research scores Armata Pharmaceuticals Inc (ARMP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ARMP.

Frequently Asked Questions

Does ARMP pay dividends?

Armata Pharmaceuticals Inc (ARMP) does not currently pay a regular dividend.

What is ARMP's market cap?

Armata Pharmaceuticals Inc (ARMP) has a market capitalization of $286.34M with a current stock price of $7.90.